title: Provider characteristics associated with guideline-nonadherent gonorrhea treatment, Massachusetts, 2010.
abstract: Emerging antibiotic resistance may be slowed through effective implementation of treatment guidelines. Our case-control study showed that providers who treated gonorrhea differently from guidelines in Massachusetts accounted for approximately 4% of cases and were associated with private practice/health maintenance organization settings and lower-incidence locations. Patient β-lactam allergy was also significantly associated with guideline nonadherence.
authors.affiliation: From the *Department of Internal Medicine, University of Texas Health Science Center at Houston, TX; and †Division of STD Prevention, Massachusetts Department of Public Health, Boston, MA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Swails
authors.forename: Laura
authors.initials: L
authors.lastname: Smock
authors.forename: Katherine
authors.initials: K
authors.lastname: Hsu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016022:Case-Control Studies; D002443:Ceftriaxone / Q000008:administration & dosage*; D024881:Drug Resistance, Bacterial; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy* / Q000453:epidemiology; D019983:Guideline Adherence; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008404:Massachusetts / Q000453:epidemiology; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone